Prostate cancer is not just a man’s concern — the use of PSA screening in transgender women

Nature Reviews Urology, Published online: 22 May 2023; doi:10.1038/s41585-023-00780-9Transgender women remain at risk of prostate cancer and warrant consideration for PSA screening. However, current PSA reference ranges and guidelines are based on data from cisgender men. As these thresholds might be inappropriate in transgender women receiving gender-affirming hormones, we recommend that these patients should undergo screening for prostate cancer at regular intervals and further evaluation for PSA >1 ng/ml or rising PSA. Furthermore patient-centred dialogues should be initiated with patients to ensure awareness of prostate cancer risk.
Source: Nature Reviews Urology - Category: Urology & Nephrology Authors: Source Type: research